Our firm is aware that the Food and Drug Administration ("FDA") is investigating Fosamax-related femur fractures. Fosamax is a drug used primarily by women fighting ostereoporosis. Several women who have been using Fosamax have reported suffering femur fractures. ABC News has reported that the drug may "limit...bone's natural ability to protect itself from stress." Besser also stated that in 2008, the FDA raised this issue with Merck (the pharmaceutical company), which more than a year later, "added information on the package insert" warning of the possibility of "low energy femoral shaft and subtrochanteric fractures." Still, the FDA has made no effort to inform the public or doctors of this side effect. These injuries appear to be occurring primarily in women who have used the drug for a number of years. There are numerous stories of patients who have suffered these femur fractures doing low-energy exercises such as walking down steps or jumping rope. These stories are particularly concerning because the femur has long been known to be one of the strongest bones in the human body.

If you or someone you care about has suffered a femur fracture or other serious injury while taking Fosamax, please contact Cole and Hodges immediately.